Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat
- PMID: 2572003
- DOI: 10.1016/0091-3057(89)90044-0
Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat
Erratum in
- Pharmacol Biochem Behav 1989 Nov;34(3):679
Abstract
Specific behaviors comprising the serotonin syndrome (low body posture, forepaw treading, headweaving) and the autonomic signs of piloerection and salivation were determined and analyzed with locomotor activity in response to MDMA at three doses (2.5, 5.0, and 7.5 mg/kg). All behaviors were dose-responsive. Serotonin syndrome behaviors increased in both intensity and duration of response with increasing doses. In contrast, locomotion varied only in intensity. Subchronic injections, in the same group of animals, permitted an analysis of acute vs. subchronic effects on these same behaviors. Both the serotonin syndrome and locomotor behaviors were augmented on subsequent testing, indicating that, (+/-)MDMA, like amphetamine, is capable of producing behavioral sensitization.
Similar articles
-
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.Neuropsychopharmacology. 1993 May;8(3):201-11. doi: 10.1038/npp.1993.22. Neuropsychopharmacology. 1993. PMID: 8099482
-
Psychostimulant properties of MDMA.NIDA Res Monogr. 1989;95:345-6. NIDA Res Monogr. 1989. PMID: 2577038 No abstract available.
-
Comparison of the behavioral and neurochemical effects of 5,7-DHT, MDMA and D,L-fenfluramine.NIDA Res Monogr. 1989;95:347. NIDA Res Monogr. 1989. PMID: 2577039 No abstract available.
-
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.Addiction. 1994 May;89(5):539-51. doi: 10.1111/j.1360-0443.1994.tb03330.x. Addiction. 1994. PMID: 7913850 Review.
-
Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").J Neurochem. 1990 Jan;54(1):14-22. doi: 10.1111/j.1471-4159.1990.tb13277.x. J Neurochem. 1990. PMID: 1967141 Review. No abstract available.
Cited by
-
Behavioral, neurochemical and pharmaco-EEG profiles of the psychedelic drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in rats.Psychopharmacology (Berl). 2013 Jan;225(1):75-93. doi: 10.1007/s00213-012-2797-7. Epub 2012 Jul 29. Psychopharmacology (Berl). 2013. PMID: 22842791
-
Role of 5-HT2A and 5-HT2C/B receptors in the acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on striatal single-unit activity and locomotion in freely moving rats.Psychopharmacology (Berl). 2005 Oct;181(4):676-87. doi: 10.1007/s00213-005-0038-z. Epub 2005 Sep 29. Psychopharmacology (Berl). 2005. PMID: 16001122
-
A developmental comparison of the neurobehavioral effects of ecstasy (MDMA).Neurotoxicol Teratol. 2007 Mar-Apr;29(2):288-300. doi: 10.1016/j.ntt.2006.10.002. Epub 2006 Oct 20. Neurotoxicol Teratol. 2007. PMID: 17174068 Free PMC article. Review.
-
Initial deficit and recovery of function after MDMA preexposure in rats.Psychopharmacology (Berl). 2006 Jan;184(2):239-46. doi: 10.1007/s00213-005-0278-y. Epub 2005 Dec 16. Psychopharmacology (Berl). 2006. PMID: 16362399
-
Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.Br J Pharmacol. 1999 Feb;126(4):911-24. doi: 10.1038/sj.bjp.0702373. Br J Pharmacol. 1999. PMID: 10193771 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources